Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Vincent Ducros"'
Autor:
Jérôme Solassol, Géraldine Chauchard, Vincent Ducros, Pauline Blateau, Estelle M.N. Laurent, Benoît Béganton, Etienne Coyaud, Julie A. Vendrell
Publikováno v:
Cancers, Vol 12, Iss 2224, p 2224 (2020)
Cancers
Cancers, 2020, 12 (8), pp.2224. ⟨10.3390/cancers12082224⟩
Cancers, MDPI, 2020, 12 (8), pp.2224. ⟨10.3390/cancers12082224⟩
Volume 12
Issue 8
Cancers
Cancers, 2020, 12 (8), pp.2224. ⟨10.3390/cancers12082224⟩
Cancers, MDPI, 2020, 12 (8), pp.2224. ⟨10.3390/cancers12082224⟩
Volume 12
Issue 8
Although the development of mitogen-activated protein kinase (MAPK) inhibitors has greatly improved the prognosis of BRAFV600 cutaneous melanomas, the identification of molecular indicators for mutated patients at risk of early progression remains a
Autor:
Carole Corsini, Pascal Pujol, Jean Chiesa, Jérôme Solassol, Jean-Marc Rey, Vincent Ducros, Julie Leclerc, Marion Larrieux
Publikováno v:
Human Mutation
Human Mutation, Wiley, 2019, 40 (6), pp.716-720. ⟨10.1002/humu.23725⟩
Human Mutation, Wiley, 2019, 40 (6), pp.716-720. ⟨10.1002/humu.23725⟩
International audience; Lynch syndrome (LS) is the most frequent cause of hereditary colorectal cancer. A subset of patients with a history of LS shows no causal germline pathogenic alteration and are identified as having Lynch‐like syndrome (LLS).
Autor:
Thierry Maudelonde, Pascal Pujol, Hanaa Aissaoui, Jean-Marc Rey, Vincent Ducros, Qing Wang, Marie-Pierre Buisine, Sylviane Olschwang
Publikováno v:
Journal of Molecular Diagnostics
Journal of Molecular Diagnostics, American Society for Investigative Pathology (ASIP), 2017, 19 (4), pp.589-601. ⟨10.1016/j.jmoldx.2017.04.005⟩
Journal of Molecular Diagnostics, 2017, 19 (4), pp.589-601. ⟨10.1016/j.jmoldx.2017.04.005⟩
Journal of Molecular Diagnostics, American Society for Investigative Pathology (ASIP), 2017, 19 (4), pp.589-601. ⟨10.1016/j.jmoldx.2017.04.005⟩
Journal of Molecular Diagnostics, 2017, 19 (4), pp.589-601. ⟨10.1016/j.jmoldx.2017.04.005⟩
International audience; Identification of genetic alterations is important for family risk assessment in colorectal cancers. Next-generation sequencing (NGS) technologies provide useful tools for single-nucleotide and copy number variation (CNV) iden